MyFinsight
Home
About
Contact
obio: the income statement
Download
Download image
Comprehensive loss
-$20,799K
(-35.90%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
$29K
(-76.03%↓ Y/Y)
Net loss
-$20,828K
(-35.02%↓ Y/Y)
Product
$140K
Partnership Revenue
$721K
Total other (expense)
income
-$515K
(-156.22%↓ Y/Y)
Loss from operations
-$20,313K
(-24.30%↓ Y/Y)
Total revenue
$861K
(-12.77%↓ Y/Y)
Interest (expense)
income, net
-$515K
(-156.22%↓ Y/Y)
Total expenses
$21,174K
(22.19%↑ Y/Y)
Selling, general and
administrative
$7,098K
(25.27%↑ Y/Y)
Research and development
$14,027K
(20.97%↑ Y/Y)
Cost of product
revenues
$49K
(-27.94%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)